AI and the Pharmaceutical Industry — 2026-09-22 (Tue)
This section covers corporate investment behaviour of pharmaceutical companies, not the efficacy or safety of any medicinal product. Headlines are quoted as published; no claim about product performance is made or implied by this site. Collection and classification are automated and may misclassify or miss items. Disclaimer
Harvested 442Accepted 13Stale 97Duplicate 93Low-quality source 14Market noise 7Market research 4Off-topic 185No investment signal 29
💰 Investment MapAmounts are extracted from source text by pattern matching only. No currency conversion.
| Amount | Deal | Function | Source |
|---|---|---|---|
| $400M | Anthropic's $400M Buy Gives New York's Life Sciences' AI Sector a Boost | 🏛️ Enterprise AI Platform & Governance | Globest |
| — | Korea's NAVER D2SF invests in AI-driven precision medicine company ImpriMed | 🏛️ Enterprise AI Platform & Governance | BioSpectrum Asia |
🧬 Drug Discovery7
- S2 Deal / PartnershipAbbVie Forms Ai-Powered Drug Discovery Partnership with Lambic | PharmExec — Pharmaceutical Executive09/22 03:57 JSTAbbVie
- S2 Deal / PartnershipTwist Bioscience Stock Gains Lilly AI Drug Discovery Partnership Exposure — simplywall.st09/21 16:34 JST
- S2 Deal / PartnershipAbbVie partners with Iambic to apply AI to small molecule drug discovery — The Pharma Letter09/22 01:45 JSTAbbVie
- S2 Deal / PartnershipAbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery — Yahoo! Finance Canada09/21 21:00 JSTAbbVieAlso reported by 1: AD HOC NEWS
- S2 Deal / PartnershipRoundup: AbbVie & Lambic Enter Ai Drug Discovery Collaboration, Telix Merges with ITM — Pharmaceutical Executive09/21 23:31 JSTAbbVie
- S2 Deal / PartnershipAbbVie Inc. (ABBV) Enters Multi‑Year AI Drug Discovery Collaboration With Iambic — TradingView09/21 21:00 JSTAbbVie
- S2 Deal / PartnershipThe Cat Health Company Partners With Ad Atomica on AI-Led De Novo Drug Discovery — einnews.com09/21 20:30 JST
🧪 Clinical Development0
No items today · See past 90 days →
📑 CTD / Regulatory Submission0
No items today · See past 90 days →
🩺 GCP Operations0
No items today · See past 90 days →
📘 ICH Guidelines & AI0
No items today · See past 90 days →
🛡️ Pharmacovigilance / GVP0
No items today · See past 90 days →
📊 RWE / Evidence Generation0
No items today · See past 90 days →
🎓 Medical Affairs0
No items today · See past 90 days →
💼 Sales0
No items today · See past 90 days →
📣 Marketing0
No items today · See past 90 days →
🚚 Distribution / Supply Chain0
No items today · See past 90 days →
✅ GQP / Quality Assurance0
No items today · See past 90 days →
👥 Human Resources0
No items today · See past 90 days →
💴 Finance & Accounting0
No items today · See past 90 days →
🏛️ Enterprise AI Platform & Governance6
- S4 Amount disclosedAnthropic's $400M Buy Gives New York's Life Sciences' AI Sector a Boost$400M — Globest09/21 21:10 JSTAnthropic
- S3 Capital moveKorea's NAVER D2SF invests in AI-driven precision medicine company ImpriMed — BioSpectrum Asia09/21 16:40 JST
- S2 Deal / PartnershipAbbVie partners with Iambic to apply AI platform across immunology, neuroscience, and oncology — AllSci09/22 00:01 JSTAbbVie
- S2 Deal / PartnershipAbbVie partners with Iambic to use AI for faste... — Pluang09/21 21:18 JSTAbbVie
- S2 Deal / PartnershipInsilico Medicine Cayman Topco Enters AI Co-Development Collaboration — TradingView09/21 19:19 JSTInsilico MedicineAlso reported by 1: marketscreener.com
- S2 Deal / PartnershipInsilico Medicine's stock rose after securing a multi‑ten‑million‑dollar collaboration to co‑develop AI models, aiming to build and commercialize biology‑based foundational models. — 富途牛牛09/21 15:13 JSTInsilico Medicine